$NERX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PONIARD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PONIARD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in PONIARD PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.74 | 5,400 | 9,396 | 127,900 | 122.5 K to 127.9 K (+4.41 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.73 | 1,700 | 2,941 | 122,500 | 120.8 K to 122.5 K (+1.41 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.72 | 2,500 | 4,300 | 120,800 | 118.3 K to 120.8 K (+2.11 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.71 | 200 | 342 | 118,300 | 118.1 K to 118.3 K (+0.17 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.70 | 400 | 680 | 118,100 | 117.7 K to 118.1 K (+0.34 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.69 | 1,500 | 2,535 | 117,700 | 116.2 K to 117.7 K (+1.29 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.68 | 200 | 336 | 116,200 | 116 K to 116.2 K (+0.17 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.67 | 500 | 835 | 116,000 | 115.5 K to 116 K (+0.43 %) |
Dec 23 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.66 | 200 | 332 | 115,500 | 115.3 K to 115.5 K (+0.17 %) |
Dec 22 2008 | NERX | PONIARD PHARMACEUT ... | De Jager Robert | Chief Medical Offic ... | Option Exercise | A | 1.78 | 60,000 | 106,800 | 185,000 | |
Dec 22 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 1.78 | 18,000 | 32,040 | 112,679 | |
Dec 22 2008 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | President & COO | Option Exercise | A | 1.78 | 75,000 | 133,500 | 958,333 | |
Dec 22 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.78 | 125,000 | 222,500 | 1,450,230 | |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.01 | 200 | 402 | 88,800 | 88.6 K to 88.8 K (+0.23 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.00 | 600 | 1,200 | 88,600 | 88 K to 88.6 K (+0.68 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.99 | 800 | 1,592 | 88,000 | 87.2 K to 88 K (+0.92 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.99 | 100 | 199 | 87,200 | 87.1 K to 87.2 K (+0.11 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.97 | 300 | 591 | 87,100 | 86.8 K to 87.1 K (+0.35 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.96 | 700 | 1,372 | 86,800 | 86.1 K to 86.8 K (+0.81 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.95 | 200 | 390 | 86,100 | 85.9 K to 86.1 K (+0.23 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.94 | 200 | 388 | 85,900 | 85.7 K to 85.9 K (+0.23 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.93 | 100 | 193 | 85,700 | 85.6 K to 85.7 K (+0.12 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.92 | 900 | 1,728 | 85,600 | 84.7 K to 85.6 K (+1.06 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.92 | 100 | 192 | 84,700 | 84.6 K to 84.7 K (+0.12 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.92 | 200 | 384 | 84,600 | 84.4 K to 84.6 K (+0.24 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.91 | 1,000 | 1,910 | 84,400 | 83.4 K to 84.4 K (+1.20 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.91 | 100 | 191 | 83,400 | 83.3 K to 83.4 K (+0.12 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.91 | 100 | 191 | 83,300 | 83.2 K to 83.3 K (+0.12 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.90 | 3,385 | 6,432 | 83,200 | 79.8 K to 83.2 K (+4.24 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.89 | 915 | 1,729 | 79,815 | 78.9 K to 79.8 K (+1.16 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.88 | 600 | 1,128 | 78,900 | 78.3 K to 78.9 K (+0.77 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.87 | 500 | 935 | 78,300 | 77.8 K to 78.3 K (+0.64 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.86 | 1,200 | 2,232 | 77,800 | 76.6 K to 77.8 K (+1.57 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.85 | 200 | 370 | 76,600 | 76.4 K to 76.6 K (+0.26 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.84 | 600 | 1,104 | 76,400 | 75.8 K to 76.4 K (+0.79 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.81 | 616 | 1,115 | 115,300 | 114.7 K to 115.3 K (+0.54 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.90 | 24,350 | 46,265 | 114,684 | 90.3 K to 114.7 K (+26.96 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.89 | 384 | 726 | 90,334 | 90 K to 90.3 K (+0.43 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.92 | 250 | 480 | 89,950 | 89.7 K to 90 K (+0.28 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.91 | 100 | 191 | 89,700 | 89.6 K to 89.7 K (+0.11 %) |
Dec 19 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.91 | 800 | 1,528 | 89,600 | 88.8 K to 89.6 K (+0.90 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 2.00 | 400 | 800 | 75,800 | 75.4 K to 75.8 K (+0.53 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.99 | 800 | 1,592 | 75,400 | 74.6 K to 75.4 K (+1.07 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.97 | 1,900 | 3,743 | 74,600 | 72.7 K to 74.6 K (+2.61 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.95 | 500 | 975 | 72,700 | 72.2 K to 72.7 K (+0.69 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.93 | 500 | 965 | 72,200 | 71.7 K to 72.2 K (+0.70 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.92 | 700 | 1,344 | 71,700 | 71 K to 71.7 K (+0.99 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.94 | 400 | 776 | 71,000 | 70.6 K to 71 K (+0.57 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.94 | 100 | 194 | 70,600 | 70.5 K to 70.6 K (+0.14 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.96 | 2,000 | 3,920 | 70,500 | 68.5 K to 70.5 K (+2.92 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.96 | 300 | 588 | 68,500 | 68.2 K to 68.5 K (+0.44 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.98 | 2,700 | 5,346 | 68,200 | 65.5 K to 68.2 K (+4.12 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.97 | 300 | 591 | 65,500 | 65.2 K to 65.5 K (+0.46 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.97 | 100 | 197 | 65,200 | 65.1 K to 65.2 K (+0.15 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.98 | 100 | 198 | 65,100 | 65 K to 65.1 K (+0.15 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.90 | 200 | 380 | 65,000 | 64.8 K to 65 K (+0.31 %) |
Dec 17 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 1.89 | 900 | 1,701 | 64,800 | 63.9 K to 64.8 K (+1.41 %) |
Dec 11 2008 | NERX | PONIARD PHARMACEUT ... | De Jager Robert | Chief Medical Offic ... | Option Exercise | A | 2.68 | 25,000 | 67,000 | 125,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 4.40 | 7,500 | 33,000 | 22,500 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Jun 25 2008 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | A | 4.40 | 15,000 | 66,000 | 15,000 | |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.94 | 100 | 394 | 30,000 | 29.9 K to 30 K (+0.33 %) |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.93 | 200 | 786 | 29,900 | 29.7 K to 29.9 K (+0.67 %) |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.92 | 1,300 | 5,096 | 29,700 | 28.4 K to 29.7 K (+4.58 %) |
Mar 07 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 3.93 | 3,900 | 15,327 | 4,733 | 833 to 4.7 K (+468.19 %) |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 5.04 | 5,833 | 29,398 | 45,823 | |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 5.97 | 38,681 | 230,926 | 76,679 | |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 5.98 | 18,000 | 107,640 | 37,998 | |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 3.66 | 7,500 | 27,450 | 19,998 | |
Mar 06 2008 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Principal Accountin ... | Option Exercise | A | 4.50 | 18,000 | 81,000 | 94,679 | |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.63 | 1,000 | 3,630 | 19,600 | 18.6 K to 19.6 K (+5.38 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.62 | 1,600 | 5,792 | 18,600 | 17 K to 18.6 K (+9.41 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.61 | 6,290 | 22,707 | 17,000 | 10.7 K to 17 K (+58.73 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.60 | 5,100 | 18,360 | 10,710 | 5.6 K to 10.7 K (+90.91 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.59 | 2,610 | 9,370 | 5,610 | 3 K to 5.6 K (+87.00 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.58 | 3,000 | 10,740 | 3,000 | 0 to 3 K |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.75 | 6,596 | 24,735 | 28,400 | 21.8 K to 28.4 K (+30.25 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.74 | 200 | 748 | 21,804 | 21.6 K to 21.8 K (+0.93 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.73 | 404 | 1,507 | 21,604 | 21.2 K to 21.6 K (+1.91 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.72 | 600 | 2,232 | 21,200 | 20.6 K to 21.2 K (+2.91 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.71 | 800 | 2,968 | 20,600 | 19.8 K to 20.6 K (+4.04 %) |
Mar 05 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Buy | P | 3.65 | 200 | 730 | 19,800 | 19.6 K to 19.8 K (+1.02 %) |
Feb 07 2008 | NERX | PONIARD PHARMACEUT ... | De Jager Robert | Chief Medical Offic ... | Option Exercise | A | 5.56 | 100,000 | 556,000 | 100,000 | |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.00 | 4,800 | 19,200 | 63,900 | 59.1 K to 63.9 K (+8.12 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.99 | 2,321 | 9,261 | 59,100 | 56.8 K to 59.1 K (+4.09 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.98 | 1,255 | 4,995 | 56,779 | 55.5 K to 56.8 K (+2.26 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.97 | 635 | 2,521 | 55,524 | 54.9 K to 55.5 K (+1.16 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.96 | 800 | 3,168 | 54,889 | 54.1 K to 54.9 K (+1.48 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.95 | 1,024 | 4,045 | 54,089 | 53.1 K to 54.1 K (+1.93 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.94 | 365 | 1,438 | 53,065 | 52.7 K to 53.1 K (+0.69 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.93 | 500 | 1,965 | 52,700 | 52.2 K to 52.7 K (+0.96 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.92 | 100 | 392 | 52,200 | 52.1 K to 52.2 K (+0.19 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.90 | 100 | 390 | 52,100 | 52 K to 52.1 K (+0.19 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.89 | 600 | 2,334 | 52,000 | 51.4 K to 52 K (+1.17 %) |
Jan 14 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 3.87 | 100 | 387 | 51,400 | 51.3 K to 51.4 K (+0.19 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.23 | 1,900 | 8,037 | 51,300 | 49.4 K to 51.3 K (+3.85 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.22 | 2,300 | 9,706 | 49,400 | 47.1 K to 49.4 K (+4.88 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.21 | 600 | 2,526 | 47,100 | 46.5 K to 47.1 K (+1.29 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.24 | 800 | 3,392 | 46,500 | 45.7 K to 46.5 K (+1.75 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.25 | 12,100 | 51,425 | 45,700 | 33.6 K to 45.7 K (+36.01 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.20 | 1,400 | 5,880 | 33,600 | 32.2 K to 33.6 K (+4.35 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.19 | 500 | 2,095 | 32,200 | 31.7 K to 32.2 K (+1.58 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.18 | 200 | 836 | 31,700 | 31.5 K to 31.7 K (+0.63 %) |
Jan 10 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.17 | 200 | 834 | 31,500 | 31.3 K to 31.5 K (+0.64 %) |
Jan 16 2008 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 5.25 | 3,809 | 19,997 | 13,368 | 9.6 K to 13.4 K (+39.85 %) |
Jan 16 2008 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 5.25 | 3,809 | 19,997 | 9,559 | 5.8 K to 9.6 K (+66.24 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.19 | 300 | 1,257 | 31,300 | 31 K to 31.3 K (+0.97 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.20 | 800 | 3,360 | 31,000 | 30.2 K to 31 K (+2.65 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.22 | 741 | 3,127 | 30,200 | 29.5 K to 30.2 K (+2.52 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.23 | 2,207 | 9,336 | 29,459 | 27.3 K to 29.5 K (+8.10 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.21 | 1,787 | 7,523 | 27,252 | 25.5 K to 27.3 K (+7.02 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.15 | 100 | 415 | 25,465 | 25.4 K to 25.5 K (+0.39 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.13 | 100 | 413 | 25,365 | 25.3 K to 25.4 K (+0.40 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.14 | 200 | 828 | 25,265 | 25.1 K to 25.3 K (+0.80 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.16 | 300 | 1,248 | 25,065 | 24.8 K to 25.1 K (+1.21 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.17 | 300 | 1,251 | 24,765 | 24.5 K to 24.8 K (+1.23 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.18 | 600 | 2,508 | 24,465 | 23.9 K to 24.5 K (+2.51 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.24 | 1,700 | 7,208 | 23,865 | 22.2 K to 23.9 K (+7.67 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.25 | 2,165 | 9,201 | 22,165 | 20 K to 22.2 K (+10.83 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.21 | 100 | 421 | 20,000 | 19.9 K to 20 K (+0.50 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.22 | 400 | 1,688 | 19,900 | 19.5 K to 19.9 K (+2.05 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.23 | 400 | 1,692 | 19,500 | 19.1 K to 19.5 K (+2.09 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.24 | 300 | 1,272 | 19,100 | 18.8 K to 19.1 K (+1.60 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.25 | 3,300 | 14,025 | 18,800 | 15.5 K to 18.8 K (+21.29 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.26 | 5,500 | 23,430 | 15,500 | 10 K to 15.5 K (+55.00 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.28 | 2,300 | 9,844 | 10,000 | 7.7 K to 10 K (+29.87 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.27 | 3,500 | 14,945 | 7,700 | 4.2 K to 7.7 K (+83.33 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.32 | 200 | 864 | 4,200 | 4 K to 4.2 K (+5.00 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.33 | 600 | 2,598 | 4,000 | 3.4 K to 4 K (+17.65 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.34 | 800 | 3,472 | 3,400 | 2.6 K to 3.4 K (+30.77 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.36 | 100 | 436 | 2,600 | 2.5 K to 2.6 K (+4.00 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.35 | 500 | 2,175 | 2,500 | 2 K to 2.5 K (+25.00 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.31 | 800 | 3,448 | 2,000 | 1.2 K to 2 K (+66.67 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.30 | 800 | 3,440 | 1,200 | 400 to 1.2 K (+200.00 %) |
Jan 07 2008 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 4.29 | 400 | 1,716 | 400 | 0 to 400 |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | WIGHT ANNA L | VP Legal | Option Exercise | A | 4.18 | 30,000 | 125,400 | 30,000 | |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | Kwok Cheni | VP, Bus. Devlpt. | Option Exercise | A | 4.18 | 30,000 | 125,400 | 30,000 | |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 4.18 | 40,000 | 167,200 | 40,000 | |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Option Exercise | A | 4.18 | 60,000 | 250,800 | 60,000 | |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | President & COO | Option Exercise | A | 4.18 | 75,000 | 313,500 | 75,000 | |
Jan 04 2008 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 4.18 | 125,000 | 522,500 | 125,000 | |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Sell | P | 5.74 | 1 | 6 | 6,520 | 6.5 K to 6.5 K (-0.02 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Sell | P | 5.74 | 7 | 40 | 395,791 | 395.8 K to 395.8 K (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.75 | 36 | 207 | 395,784 | 395.7 K to 395.8 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.90 | 85 | 502 | 6,519 | 6.4 K to 6.5 K (+1.32 %) |